Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correction Notice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619888/
https://www.ncbi.nlm.nih.gov/pubmed/37920708
http://dx.doi.org/10.1097/HS9.0000000000000987
Descripción
Sumario:

Ejemplares similares